219 results on '"Sedegah M"'
Search Results
2. DNA Vaccination as an Approach to Malaria Control: Current Status and Strategies
3. Cytotoxic T Lymphocytes in Humans Exposed to Plasmodium falciparum by Immunization or Natural Exposure
4. Plasma concentrations of transforming growth factor beta 1 in non-progressive HIV-1 infection correlates with markers of disease progression
5. In vitro Survival and Retention of Infectivity of Plasmodium yoelii Sporozoites over Extended Periods of Time
6. Effect on antibody and T-cell responses of mixing five GMP-produced DNA plasmids and administration with plasmid expressing GM-CSF
7. Reduced immunogenicity of DNA vaccine plasmids in mixtures
8. Transfusion-Transmitted Malaria in Adult Semi-Immune Patients from Hyperendemic Area: SP407
9. The Infectivity of Plasmodium yoelii in Different Strains of Mice
10. Cross-protection between attenuated Plasmodium berghei and P. yoelii sporozoites
11. CD4+ T cell counts in initiation of antiretroviral therapy in HIV infected asymptomatic individuals; controversies and inconsistencies
12. Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine
13. DNA vaccines for malaria: the past, the present,the future
14. In vitro expression and in vivo immunogenicity of Plasmodium falciparum pre-erythrocytic stage DNA vaccines.
15. Sterile protection of monkeys against malaria after administration of interleukin-12
16. Induction of neonatal tolerance by plasmid DNA vaccination of mice.
17. Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity.
18. Nucleic Acid Malaria Vaccines.
19. Interleukin-12 and malaria
20. Complexity of the cytokine and antibody response elicited by immunizing mice with Plasmodium yoelii circumsporozoite protein plasmid DNA.
21. Plasmodium yoelii: 17-kDa Hepatic and Erythrocytic Stage Protein Is the Target of an Inhibitory Monoclonal Antibody
22. Protection against malaria by immunization with a Plasmodium yoelii circumsporozoite protein nucleic acid vaccine
23. Interleukin 12 induction of interferon gamma-dependent protection against malaria.
24. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein.
25. Complete protection against Plasmodium yoelii by adoptive transfer of a CD8+ cytotoxic T-cell clone recognizing sporozoite surface protein 2
26. Prospects and strategies for development of DNA vaccines against malaria
27. The role of CD4+ T cells in immunity to malaria sporozoites.
28. Monoclonal antibodies of three different immunoglobulin G isotypes produced by immunization with a synthetic peptide or native protein protect mice against challenge with Plasmodium yoelii sporozoites
29. A T cell clone directed at the circumsporozoite protein which protects mice against both Plasmodium yoelii and Plasmodium berghei.
30. Naturally acquired CD8+ cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein.
31. Recombinant pseudorabies virus carrying a plasmodium gene: herpesvirus as a new live viral vector for inducing T- and B-cell immunity☆
32. Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein
33. Monoclonal, but not polyclonal, antibodies protect against Plasmodium yoelii sporozoites.
34. Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes.
35. DNA vaccination against malaria
36. Plasmodium yoelii:17-kDa Hepatic and Erythrocytic Stage Protein Is the Target of an Inhibitory Monoclonal Antibody
37. CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites.
38. Simultaneous induction of multiple antigen-specific cytotoxic T lymphocytes in nonhuman primates by immunization with a mixture of four Plasmodium falciparum DNA plasmids.
39. Characterization of Plasmodium yoelii monoclonal antibodies directed against stage-specific sporozoite antigens
40. DNA vaccination as an approach to malaria control: current status and strategies
41. Cloning of Plasmodium yoelii genes expressing three different sporozoite-specific antigens
42. Measuring naturally acquired immune responses to candidate malaria vaccine antigens in Ghanaian adults
43. Identification of two new protective pre-erythrocytic malaria vaccine antigen candidates
44. Identification and localization of minimal MHC-restricted CD8+ T cell epitopes within the Plasmodium falciparum AMA1 protein
45. Partial protection against malaria by immunization with Leishmania enriettii expressing the Plasmodium yoelii circumsporozoite protein
46. Live Attenuated Malaria Vaccine Designed to Protect Through Hepatic CD8+ T Cell Immunity.
47. Protection against malaria induced by irradiated sporozoites.
48. Plasmodium falciparum AMA1 and CSP antigen diversity in parasite isolates from southern Ghana.
49. Induction of antigen specific intrahepatic CD8+ T cell responses by a secreted heat shock protein based gp96-Ig-PfCA malaria vaccine.
50. Immunodominant T cell peptides from four candidate malarial antigens as biomarkers of protective immunity against malaria.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.